832 related articles for article (PubMed ID: 24140093)
1. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system.
Dalamaga M; Karmaniolas K; Nikolaidou A; Chamberland J; Hsi A; Dionyssiou-Asteriou A; Mantzoros CS
Eur J Cancer; 2008 Aug; 44(12):1744-53. PubMed ID: 18515085
[TBL] [Abstract][Full Text] [Related]
3. Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study.
Dalamaga M; Nikolaidou A; Karmaniolas K; Hsi A; Chamberland J; Dionyssiou-Asteriou A; Mantzoros CS
Oncology; 2007; 73(1-2):26-32. PubMed ID: 18337619
[TBL] [Abstract][Full Text] [Related]
4. Leptin, soluble leptin receptors, free leptin index, and their relationship with insulin resistance and BMI: high normal BMI is the threshold for serum leptin increase in humans.
Owecki M; Nikisch E; Miczke A; Pupek-Musialik D; Sowiński J
Horm Metab Res; 2010 Jul; 42(8):585-9. PubMed ID: 20455195
[TBL] [Abstract][Full Text] [Related]
5. Plasma adiponectin and insulin sensitivity in overweight and normal-weight middle-aged premenopausal women.
Jürimäe J; Jürimäe T; Ring-Dimitriou S; LeMura LM; Arciero PJ; von Duvillard SP
Metabolism; 2009 May; 58(5):638-43. PubMed ID: 19375586
[TBL] [Abstract][Full Text] [Related]
6. Measurement of serum cytokine levels in patients with myelodysplastic syndromes.
Verhoef GE; De Schouwer P; Ceuppens JL; Van Damme J; Goossens W; Boogaerts MA
Leukemia; 1992 Dec; 6(12):1268-72. PubMed ID: 1280751
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
8. Serum adiponectin and leptin levels and insulin resistance in children born large for gestational age are affected by the degree of overweight.
Giapros V; Evagelidou E; Challa A; Kiortsis D; Drougia A; Andronikou S
Clin Endocrinol (Oxf); 2007 Mar; 66(3):353-9. PubMed ID: 17302868
[TBL] [Abstract][Full Text] [Related]
9. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype.
Phillips CM; Tierney AC; Perez-Martinez P; Defoort C; Blaak EE; Gjelstad IM; Lopez-Miranda J; Kiec-Klimczak M; Malczewska-Malec M; Drevon CA; Hall W; Lovegrove JA; Karlstrom B; Risérus U; Roche HM
Obesity (Silver Spring); 2013 Jan; 21(1):E154-61. PubMed ID: 23505198
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
Abdullah AR; Hasan HA; Raigangar VL
Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of myelodysplastic syndromes: a case-control study.
Strom SS; Gu Y; Gruschkus SK; Pierce SA; Estey EH
Leukemia; 2005 Nov; 19(11):1912-8. PubMed ID: 16167059
[TBL] [Abstract][Full Text] [Related]
12. Fetuin-A, adiposity-linked insulin resistance and responsiveness to an educational-based weight excess reduction program: a population-based survey in prepubertal schoolchildren.
Murdolo G; Tortoioli C; Celi F; Bini V; Papi F; Brozzetti A; Falorni A
Endocrine; 2017 May; 56(2):357-365. PubMed ID: 27388590
[TBL] [Abstract][Full Text] [Related]
13. Effect of weight loss on high-molecular weight adiponectin in obese children.
Martos-Moreno GÁ; Barrios V; Martínez G; Hawkins F; Argente J
Obesity (Silver Spring); 2010 Dec; 18(12):2288-94. PubMed ID: 20339359
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum TNF-alpha concentrations are predictive of shortened survival in patients with high-risk myelodysplastic syndromes.
Alexandrakis M; Coulocheri S; Xylouri I; Ganotakis E; Eliakis P; Karkavitsas N; Eliopoulos GD
Haematologia (Budap); 1998; 29(1):13-24. PubMed ID: 9704253
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin gene expression and adipocyte NF-kappaB transcriptional activity in elderly overweight and obese women: inter-relationships with fat distribution, hs-CRP, leptin and insulin resistance.
Zamboni M; Di Francesco V; Garbin U; Fratta Pasini A; Mazzali G; Stranieri C; Zoico E; Fantin F; Bosello O; Cominacini L
Int J Obes (Lond); 2007 Jul; 31(7):1104-9. PubMed ID: 17325687
[TBL] [Abstract][Full Text] [Related]
16. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.
Berer A; Jäger E; Sagaster V; Streubel B; Wimazal F; Sperr WR; Welterman A; Schwarzinger I; Frommlet F; Haas OA; Valent P; Lechner K; Geissler K; Ohler L
Ann Hematol; 2003 May; 82(5):271-7. PubMed ID: 12739063
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndromes: a community hospital-based study of prognostic factors and International Prognostic Scoring System.
Mirza I; Garzón R; Burns J; Edwards L; Fernandez-Cymering C; Kloss R
Conn Med; 2001 Aug; 65(8):455-63. PubMed ID: 11550445
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin.
Chu MC; Cosper P; Orio F; Carmina E; Lobo RA
Am J Obstet Gynecol; 2006 Jan; 194(1):100-4. PubMed ID: 16389017
[TBL] [Abstract][Full Text] [Related]
19. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
[TBL] [Abstract][Full Text] [Related]
20. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
